title: [Hybrid PET/CT in cancer imaging].
abstract: Combination of positron emission tomography (PET) and computed tomography (CT) has revolutionized imaging of cancer. The most often used PET tracer is fluorodeoxyglucose (FDG). FDG-PET/CT shows the extent of the disease more accurately than either CT or MRI alone. With FDG-PET/CT imaging, up to 30% more patients are presented with unexpected distant metastases. This helps to guide patient management.
authors.affiliation: TYKS:n isotooppiosasto ja PET-keskus, TYKS Kantasairaala, Turku.
authors.forename: Marko
authors.initials: M
authors.lastname: Seppänen
authors.forename: Sami
authors.initials: S
authors.lastname: Kajander
authors.forename: Jukka
authors.initials: J
authors.lastname: Kemppainen
authors.forename: Heikki
authors.initials: H
authors.lastname: Minn
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging; D009369:Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18